Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

The recall has been issued for some products due to higher than acceptable levels of benzene, a chemical linked to leukemia ...

The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

For more on Immunovant’s new data, go here; for more on Sarepta’s gene therapy, go here; to learn more about Zealand’s deal with Roche, go here; and to read about the panels at our Breakthrough East ...

While the clinical dementia findings did not reach statistical significance, they were the first to provide a hint that early ...

The FDA said testing of certain acne products with benzoyl peroxide found elevated levels of benzene, a chemical linked to cancer.